| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $59.0M | +74.2% |
| SG&A Expense | $19.2M | +32.0% |
| Operating Income | -$78.2M | -61.6% |
| Pre-tax Income | -$71.1M | -11.4% |
| Income Tax | $0 | — |
| Net Income | -$71.1M | -11.4% |
| EPS (Basic) | -$6.63 | +82.6% |
| EPS (Diluted) | -$6.63 | +82.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $354.3M | +1537.2% |
| Current Assets | $357.1M | +1311.1% |
| Total Assets | $358.2M | +1281.9% |
| Current Liabilities | $27.8M | -52.3% |
| Long-term Debt | $8.5M | +3.7% |
| Total Liabilities | $35.1M | -47.3% |
| Stockholders' Equity | $323.1M | +286.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.5M | -37.9% |
| Capital Expenditures | $366K | +120.5% |
| Investing Cash Flow | -$366K | -37.6% |
| Financing Cash Flow | $381.2M | +991.0% |
| Free Cash Flow | -$51.9M | -38.3% |